BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...
-
Bayer's next CEO has a year to prepare Today
-
Bayer AG tabs outsider as CEO's successor
-
Bayer Unveils Management Shuffle
News & Analysis
Filter by
agreement and bayer ag - All News and Analysis
Why the Bayer-Yaz Settlement Will Not Change Drug Advertising Forever
Former Pfizer vp Dorothy Wetzel popped up in Ad Age today claiming that Bayer's corrective ad campaign for Yaz birth control "will cause drug companies to get way more conservative" with their advertising. "They're going to test and test and test their spots, and ultimately the advertising won't be as...
ADAPCO Named Exclusive Distributor of Aqua-Reslin®; Exclusivity Agreement Marks Second Such Arrangement Between ADAPCO and Bayer Vector/Mosquito Control
SANFORD, Fla. -- ADAPCO, Inc. has been named the exclusive distributor of Aqua-ReslinR, the highly regarded water-based mosquito adulticide, featuring the innovative Film-Forming Aqueous Spray Technology FFAST.
Bayer Animal Health and Bayer Environmental Science Announce Exclusive Distribution Agreement
Bayer Animal Health and Bayer Environmental Science, a division of Bayer CropScience, announce an exclusive distribution agreement for the sales and marketing of Bayer Environmental Science branded products in the farm hygiene market.
Stratagene and Bayer HealthCare Enter Development and Supply Agreement for QPCR Instruments
LA JOLLA, Calif. -- Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that Bayer HealthCare, Diagnostics Division, a member of the Bayer Group (NYSE:BAY), will purchase customized Mx3005PTM instrument systems for use in a new platform Bayer is developing for...
Stratagene Reports Fourth Quarter Results; 2005 Annual Revenue Up 54%; QPCR Instrument Agreement With Bayer Healthcare Announced; Company Provides 2006 Guidance
LA JOLLA, Calif. -- Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, today released financial results for the fourth quarter and full year ended December 31, 2005.
PHYSIOMICS PLC - Re Agreement.
Physiomics and Bayer Technology Services sign UK distribution agreement for PK-SimA' ...
Bayer Biological Products Signs Exclusive Agreement with World Federation of Hemophilia to Fund International Nursing Fellowship Program; Bayer BP Strengthens Its Commitment to the Global Hemophilia Community
BERKELEY, Calif. -- Bayer Biological Products BP announced today the launch of the World Federation of Hemophilia's WFH International Hemophilia Nursing Fellowship Program, a new fellowship program providing state-of-the-art hemophilia education and training to nurses in developing countries. The program will extend the benefits of WFH's highly successful International Hemophilia...
Bayer Reaches Agreement With U.S. Department of Justice in Acrylonitrile-Butadiene Rubber Investigation
LEVERKUSEN -- Bayer AG today confirmed that it has reached agreement with the U.S. Department of Justice to settle charges related to allegations that it engaged in anti-competitive activities from May 2002 through December 2002 involving acrylonitrile-butadiene rubber. Under the terms of the agreement, Bayer agreed to plead guilty and...
Bayer HealthCare has made an agreement to have its primary-care pharmaceuticals marketed and distributed in the U.S. by Schering-Plough Corp
* Bayer HealthCare has made an agreement to have its primary-care pharmaceuticals marketed and distributed in the U.S. by Schering-Plough Corp. This will allow Bayer to focus on high-profit biotech and specialty products.
Bayer and Pennsylvania Reach Economic Stimulus Agreement
PITTSBURGH -- Bayer Corporation today announced an agreement with the Commonwealth of Pennsylvania to help bolster the Pennsylvania economy through local capital investment and job retention.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
